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Abstract 
Background: The importance of the submicroscopic reservoir of Plasmodium infections for malaria elimination 
depends on its size, which is generally considered small in low transmission settings. The precise estimation of this 
reservoir requires more sensitive parasite detection methods. The prevalence of asymptomatic, sub‑microscopic 
malaria was assessed by a sensitive, high blood volume quantitative real‑time polymerase chain reaction method in 
three countries of the Greater Mekong Sub‑region.
Methods: Cross‑sectional surveys were conducted in three villages in western Cambodia, four villages along the 
Thailand–Myanmar border and four villages in southwest Vietnam. Malaria parasitaemia was assessed by Plasmodium 
falciparum/pan malaria rapid diagnostic tests (RDTs), microscopy and a high volume ultra‑sensitive real‑time polymer‑
ase chain reaction (HVUSqPCR: limit of detection 22 parasites/mL). All villagers older than 6 months were invited to 
participate.
Results: A census before the surveys identified 7355 residents in the study villages. Parasite prevalence was 224/5008 
(4 %) by RDT, 229/5111 (5 %) by microscopy, and 988/4975 (20 %) when assessed by HVUSqPCR. Of these 164 (3 %) 
were infected with P. falciparum, 357 (7 %) with Plasmodium vivax, 56 (1 %) with a mixed infection, and 411 (8 %) had 
parasite densities that were too low for species identification. A history of fever, male sex, and age of 15 years or older 
were independently associated with parasitaemia in a multivariate regression model stratified by site.
Conclusion: Light microscopy and RDTs identified only a quarter of all parasitaemic participants. The asymptomatic 
Plasmodium reservoir is considerable, even in low transmission settings. Novel strategies are needed to eliminate this 
previously under recognized reservoir of malaria transmission.
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Background
Eliminating the submicroscopic reservoir of Plasmodium 
infections in asymptomatic carriers may play a critical 
role in the elimination of malaria [1]. In low transmis-
sion settings, such as in countries of the Greater Mekong 
Sub-region (GMS), asymptomatic carriage is generally 
considered to be low. Estimates of the asymptomatic res-
ervoir size largely relying on methods with limited sensi-
tivity have prevented a more complete understanding of 
the epidemiology of malaria. Light microscopy and rapid 
diagnostic tests (RDT) have comparable lower limits of 
detection. Assessment by calibration with spiked samples 
shows a limit between 10 and 100 parasites/µL (10,000–
100,000/mL) for microscopy of a thick blood film [2]. In 
comparison PCR methods have better sensitivity, typi-
cally detecting 5–10  parasites/µL (5000–10,000/mL), 
although sensitivity depends on the volume of blood 
examined [3, 4]. For instance, in a filter paper blood spot 
of 5 µL (0.005 mL), parasite densities lower than 1/5 µL 
(=200 parasites/ml) are unlikely to be detected irrespec-
tive of the sensitivity of the PCR method itself.
A series of cross sectional surveys were conducted along 
the Thailand–Myanmar border, in Western Cambodia, 
and Vietnam using a sensitive PCR detection method 
based on larger blood volumes than conventional PCR 
methods use [5]. In the context of the threat of artemisinin 
and multi drug resistant falciparum malaria, countries 
in the GMS have adopted recently a malaria elimination 
agenda. The findings of these prevalence studies are criti-
cal to target interventions for malaria elimination.
Methods
Surveys were performed in malaria-endemic areas along 
the Thailand–Myanmar border, in western Cambo-
dia, and south-western Vietnam (Fig.  1). In these areas, 
malaria transmission is low, heterogeneous, and seasonal 
with entomological inoculation rates generally below 
one/person/year. The majority of clinical cases occur 
during the rainy season between May and December 
[6–9]. Plasmodium vivax and P. falciparum have his-
torically each comprised approximately half the clinical 
cases, although with recent reductions in overall malaria 
incidence, P. vivax now predominates [10]. The region 
has been recognized as the origin of anti-malarial drug 
resistance in P. falciparum to chloroquine, sulfadox-
ine-pyrimethamine and mefloquine. More recently, P. 
Fig. 1 South East Asia, with markers for the position of the study sites in Thailand–Myanmar border areas, Cambodia and two sites in Vietnam
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falciparum strains with reduced susceptibility to arte-
misinins have been detected in this region [11–14].
Locations
Thailand–Myanmar border
In response to large numbers of malaria cases in Myan-
mar close to the North-western border with Thailand 
and requests for assistance, health posts with facilities 
for malaria diagnosis and treatment were installed in 
several villages. These were the focal point for the con-
duct of limited cross- sectional surveys in 16 villages to 
plan optimum control interventions (Additional file  1: 
Table S1). Based on the findings more exhaustive surveys 
were conducted in four villages (HKT, KNH, TOT, TPN) 
located within 10 km of the Thailand border considered 
representative of the area in terms of environment, ecol-
ogy, population, and behaviour.
Cambodia
Plasmodium falciparum with reduced susceptibility 
to artesunate monotherapy was first detected in Bat-
tambang [15] and then Pailin, Western Cambodia [12]. 
Many of the containment efforts in Cambodia have been 
focused on Pailin resulting in a marked decline in clini-
cal malaria incidence over the last few years [16–20]. 
In 2013, the Cambodian National Malaria Control Pro-
gramme and Mahidol-Oxford Research Unit formed a 
malaria research team based in Pailin Referral Hospital to 
investigate if there are areas with significant subclinical 
malaria parasitaemia. Three villages (KL, OK, and PDB) 
were selected based on the highest incidence of clinical 
falciparum malaria in the village malaria workers’ records 
from 2012.
Vietnam
Malaria remains a public health challenge in Vietnam 
despite a substantial reduction in the incidence of dis-
ease over the last 20  years. Since 2010, studies in Binh 
Phuoc province show an increased proportion of slow 
clearing artemisinin-resistant infections [11], but still 
with satisfactory cure rates with ACT (dihydroarte-
misinin–piperaquine) [21]. Two villages (BK and BB) in 
Dak O commune of Binh Phuoc and two villages (GIA 
and THA) in Ninh Thuan province were selected for 
further evaluation based on surveillance data from pilot 
studies. The study in Vietnam has been conducted in col-
laboration with malaria control programme of Vietnam 
(Institute of Malariology, Parasitology, and Entomology 
(IMPE) Ho Chi Minh City and IMPE Qui Nhon).
Procedures
In each village a committee was formed composed of vil-
lage leaders, village malaria workers, and volunteers. The 
committees assisted the study team in organizing the 
survey and in engaging and mobilizing the community. A 
census was performed before the survey.
During the surveys all individuals aged 6  months or 
above were invited to participate, including temporary 
residents and migrant workers. Individual informed con-
sent was obtained from adults, and parental consent for 
the participation of children under 16  years. No addi-
tional assent was obtained from adolescents. Demo-
graphic information was collected and the tympanic 
temperature, weight, and height of all individuals were 
measured. A brief history of recent illness and travel was 
also obtained. Venous blood (3  mL) was collected from 
all individuals aged ≥5  years, and 500  µL from chil-
dren aged ≥6  months–5  years. Participants with fever 
≥37.5 °C were tested for malaria by rapid diagnostic test 
(RDT), and were treated if positive according to national 
guidelines.
The blood samples were stored in a cool box in the field 
and then transported within 12 h to the local laboratory 
for further sample processing and RDT assessment. In 
Cambodia, the Healgen malaria P. falciparum/Pan one-
step RDT was used (Zhejiang Orient Biotech, China); in 
Thailand–Myanmar border areas and in Vietnam, the 
SD Bioline Malaria Ag Pf/Pan POCT was used (Cat. 
No. 05FK60; 65, Borahagal-ro, Giheung-gu, Yongin-si, 
Gyeonggi-do, Republic of Korea). The RDTs distinguish 
between P. falciparum infections, non-P. falciparum infec-
tions, and no infections. Haemoglobin was measured 
using Hemocue (Ängelholm, Sweden). Sample processing 
for the quantitative PCR included separation of plasma, 
buffy coat, and packed red blood cells, which were fro-
zen and stored at −80  °C. The frozen samples from the 
Thailand–Myanmar Border and Cambodia were trans-
ported monthly on dry ice to the laboratory in Bangkok, 
Thailand and the samples from the Vietnam sites were 
shipped to Ho Chi Minh City, Vietnam for DNA extrac-
tion and quantitative PCR.
Quantification of malaria parasitaemia
Standard microscopy was performed by microsco-
pists who had at least 5  years experience and/or were 
confirmed to be Level 2 or better with a WHO 55 slide 
set. The number of parasites/500 white blood cells was 
counted on Giemsa-stained thick films.
Detailed description, evaluation and validation of the 
high-volume ultrasensitive real-time polymerase chain 
reaction (HVUSqPCR) methods have been reported 
recently in detail [5]. In summary, the DNA template for 
PCR detection and quantification of Plasmodium was 
purified from the thawed packed red blood cells sam-
ples. Purified DNA was dehydrated in a centrifugal vac-
uum concentrator and then suspended in a small volume 
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of PCR grade water resulting in a concentration factor 
defined by the original blood volumes (100–2000  μL) 
divided by the resuspension volume (10–50  µL). Two 
microlitres of resuspended DNA was used as template in 
the qPCR reaction. The presence of malaria parasites and 
an estimate of the parasite numbers (genomes) in each 
sample were assessed by an absolute quantitative real-
time PCR (qPCR) method (Quanti-Tect Multiplex PCR 
No ROX®, QIAGEN, Germany). The 18S rRNA-target-
ing primers and hydrolysis probes used in the assay have 
been validated and are highly specific for Plasmodium 
species [22]. The lower limit of accurate quantitation of 
this method is 22 parasites/ml of whole blood [14].
For samples where the HVUSqPCR was positive, an 
attempt was made to determine the Plasmodium species 
present using nested PCR protocols specific to P. falcipa-
rum (microsatellite marker Pk2), P. vivax (microsatellite 
marker 3.502) and Plasmodium malariae (18s rRNA) as 
described previously [22–24]. Samples for which there 
was insufficient DNA to do this, or where no amplifica-
tion was obtained in this step were reported as being of 
indeterminate species (Plasmodium spp.).
Statistical analyses
For the purposes of analysis, fever was defined as a tym-
panic temperature >37.5  °C. Anaemia was defined as 
“None” if the haemoglobin (Hb) was ≥11 g/dL, “Mild” if 
Hb ≥8–<11 g/dL, and “Moderate” if Hb <8 g/dL. Charac-
teristics of the study population and clinical association 
with presence of parasitaemia were compared using the 
Chi squared test. Nonparametric testing for trend was 
performed using the nptrend command in STATA which 
is based on the Wilcoxon rank-sum test. The detection 
of parasitaemia was summarized by location, age and 
gender strata as specified a priori in the analysis plan. 
Sensitivities and specificities for malaria diagnosis were 
calculated using HVUSqPCR as the reference standard. 
Overall and study location specific risk factors for para-
site carriage (detected by HVUSqPCR) were assessed 
by logistic regression with household fitted as a random 
effect. For all models, a stepwise approach was used and 
only variables significant at the 0.05 level were retained 
in the final models. All analyses were performed using 
Stata, version 13 (StataCorp, College Station, TX, USA).
Ethics approval
The studies were approved by the Cambodian National 
Ethics Committee for Health Research (0029 NECHR, 
dated 04 Mar 2013) the Institute of Malariology, Para-
sitology and Entomology in Ho Chi Minh City (185/
HDDD dated 15 May 2013), the Institute of Malariology, 
Parasitology and Entomology in Qui Nhon (dated 14 Oct 
2013) and the Oxford Tropical Research Ethics Commit-
tee (1015-13, dated 29 Apr 2013).
Results
A census prior to the surveys identified 7355 residents in 
11 study villages, 1766 in three Cambodian villages (KL, 
OK, and PDB), 2377 in four villages along the Thailand–
Myanmar border (TOT, TPN, KNH, and HKT) and 3212 
in four villages in Vietnam (BB, BK, THA, GIA) (Fig. 2). 
In Cambodia the surveys were conducted in June 2013, 
along the Thailand–Myanmar border between May and 
July 2013, and in October and November 2013 in Viet-
nam. Of the census population, 83  % participated in 
the surveillance in the Cambodian villages, 67  % in vil-
lages along the Thailand–Myanmar border and 67  % in 
the Vietnamese villages. The most frequently reported 
reasons for non-participation were problems related to 
travel and refusal of consent (Additional file 2).
Characteristics of the study population
The population of the 11 participating villages were com-
parable in age distributions; the median age of the par-
ticipants was 21 years with 37 % of the participants under 
15-year-old (Table  1; data disaggregated by village are 
shown in Additional file  3). Of the 741 children under 
72  months who participated in the study 57 (8  %) were 
febrile (tympanic temperature >37.5 °C) on the day of the 
examination. In the Vietnamese sites the proportion of 
febrile children was 1 % in contrast to 10 % in the Thai-
land–Myanmar border areas and the Cambodian sites 
(p  =  0.001; Table  1). Moderate anaemia (Hb <8  g/dL) 
was present in 5  % of children in the Vietnamese sites, 
3  % of children in the Thailand–Myanmar border areas 
and 2 % in the Cambodian sites (p < 0.009). Younger age 
was associated with a higher prevalence of fever and 
anaemia compared to older age (p < 0.0001; Fig. 3). The 
prevalence of fever increased with the severity of anae-
mia: 3 % in participants with an Hb ≥11 g/dL, 5 % with 
8 ≤ Hb < 11 g/dL and 9 % in the group with Hb <8 g/dL 
(2 d.f.; p = 0.002).
Detection of Plasmodium parasitaemia
Using rapid diagnostic tests (RDT) overall 224/5008 
(4 %) participants tested positive (Table 2). Only 1/1447 
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Fig. 2 Assembly of study participants
Table 1 Study population characteristics in the malaria surveys
IQR inter-quartile range, y.o. years old, m.o. months old, g/dL grams per decilitre
a Tympanic temperature >37.5 °C
Cambodia Thai–Myanmar border areas Vietnam Overall
Median age, years (IQR, range) 21 (9–35, 0.3–83) 20 (9–37, 0.2–94) 22 (10–36, 0.1–94) 21 (9–36, 0.1–94)
Children <15 y.o. (%) 660/1766 (37 %) 923/2373 (39 %) 1112/3194 (35 %) 2695/7333 (37 %)
Male (%) 901/1766 (51 %) 1265/2377 (53 %) 1619/3207 (50 %) 3785/7350 (51 %)
Children <72 m.o. and febrile (%)a 25/242 (10 %) 30/315 (10 %) 2/184 (1 %) 57/741 (8 %)
No anaemia (Hb ≥11 g/dL) 1243 (86 %) 1319 (87 %) 1535 (74 %) 4097 (81 %)
Mild anaemia (Hb 8–<11 g/dL) 188 (13 %) 182 (12 %) 445 (21 %) 815 (16 %)
Moderate anaemia (Hb <8 g/dL) 15 (1 %) 18 (1 %) 91 (4 %) 124 (2 %)
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participants in the Cambodian sites tested positive 
compared with 158/1384 (11  %) along the Thailand–
Myanmar border and 65 of 2177 (3 %) in Vietnam. With 
microscopy 229/5111 (5  %) showed Plasmodium para-
sites; 1 % in Cambodia, 4 % in Vietnam and 9 % on the 
Thailand–Myanmar border. Using HVUSqPCR 988/4975 
(20 %) participants’ blood samples tested positive for the 
presence of Plasmodium DNA, of which 164/4975 (3 %) 
were P. falciparum, 357 (7  %) P. vivax, 56 (1  %) were 
mixed infections and in 411 (8 %) of specimens it was not 
possible to determine the species because of the low par-
asite DNA content. The data disaggregated by village are 
shown in Additional file 4. No Plasmodium species other 
than P. falciparum and P. vivax were detected.
Using HVUSqPCR as the reference-standard, the over-
all sensitivity for RDTs to detect P. falciparum infections 
was 44 % with a specificity of 99 % (Table 3). The sensi-
tivity of RDTs for detecting non-P. falciparum infections 
was only 14 % with a specificity of 100 %. Sensitivity of 
microscopy compared to HVUSqPCR was similar for 
P. falciparum (30 %) and for P. vivax (35 %; Table 4; the 
disaggregated data are shown in Additional file  5). The 
sensitivity of both RDTs (range 0–68 %) and microscopy 
(range 0–40 %) for detecting asymptomatic malaria was 
variable between sites, whereas specificity for both RDTs 
(range 97–100  %) and microscopy (100  %) was high in 
all sites. Sensitivity of RDTs and microscopy was better 
Fig. 3 The correlations between anaemia, fever and age. Younger participants were more likely to be febrile and anaemic (Hb < 11 g/dL)
Table 2 The results of  RDT, light microscopy, and 
HVUSqPCR in Cambodia, Thailand–Myanmar border areas, 
and Vietnam
N, number; No. pos, number positive; mixed, mixed infections P. falciparum and 
P. vivax; Pf, P. falciparum; non-PF, Plasmodium species other than P. falciparum; 
Pv P. vivax





 n 1447 1384 2177 5008
 No. pos 1 (0.1 %) 158 (11 %) 65 (3 %) 224 (5 %)
 Pf 1 (0.1 %) 108 (8 %) 39 (2 %) 148 (3 %)
 Non‑PF 0 50 (4 %) 18 (1 %) 68 (1 %)
 Mixed 0 0 8 (0.4 %) 8 (0.2 %)
Microscopya
 n 1447 1532 2132 5111
 No. pos 8 (1 %) 144 (9 %) 77 (4 %) 229 (5 %)
 Pf 1 (0.1 %) 39 (3 %) 27 (1 %) 67 (1 %)
 Pv 7 (0.5 %) 105 (7 %) 46 (2 %) 158 (3 %)
HVUSqPCR
 n 1447 1536 1992 4975
 No. pos 229 (16 %) 520 (34 %) 239 (12 %) 988 (20 %)
 Pf 32 (2 %) 87 (6 %) 45 (2 %) 164 (3 %)
 Pv 48 (3 %) 230 (15 %) 79 (4 %) 357 (7 %)
 Mixed 4 (0.3 %) 21 (1 %) 31 (2 %) 56 (1 %)
 P. spp. 145 (10 %) 182 (12 %) 84 (4 %) 411 (8 %)
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at higher parasite densities (Fig. 4). In the very low para-
sitaemias in which species could not be determined by 
PCR (Plasmodium spp.), the sensitivity of RDTs was 5 % 
and of microscopy 3 %.  
Epidemiological and clinical associations with Plasmodium 
infections
Parasite prevalence detected by HVUSqPCR was low-
est in Vietnam (239/1992; 12 %), followed by Cambodia 
(16 %; 229/1447) and (34 %; 520/1536) on the Thailand–
Myanmar border (p  <  0.0001; Fig.  5). Parasitaemia was 
detected in all age groups and prevalence increased with 
age (Additional file  6). In every village parasite preva-
lence was higher in males (592/2462; 24 %) compared to 
females (396/2509; 16 %; p < 0.0001).
A total of 10/152 (7 %) participants with P. falciparum 
infections detected by HVUSqPCR were febrile on the 
day of the survey in contrast to 14/323 (4 %) with P. vivax 
infections, 112/3412 (3  %) without parasitaemia and 
0/48 with mixed infections (comparison P. falciparum 
and negatives: p = 0.038; comparison P. vivax and nega-
tives p = 0.3 and comparison P. falciparum and P. vivax 
p = 0.4). The geometric mean (95 %CI) parasite density 
in the 47 febrile patients was 3729 (755–18,420) para-
sites/mL, compared to 1151 (905–1464) parasites/mL 
in afebrile individuals. For both P. falciparum or P. vivax 
was it impossible to determine a clearly delineated pyro-
genic parasite density threshold (Fig. 6).
In participants carrying P. falciparum, mild anaemia 
(Hb 8–<11  g/dL) was present in 30/163 (18  %) partici-
pants and moderate anaemia (Hb <8 g/dL) in 7/163 (4 %) 
(Table  5). Among the participants with P. vivax 39/354 
(11 %) had mild anaemia and 5/354 (1 %) had moderate 
anaemia (for comparison mild anaemia between Pf and 
Pv p = 0.026; comparison moderate anaemia p = 0.058). 
Among 3889 participants without evidence of parasitae-
mia by any detection method 619 (16 %) had mild anae-
mia and 96 (2  %) had moderate anaemia. Parasitaemic 
Table 3 Species specific sensitivity, specificity, positive predictive value and negative predictive value of RDTs compared 
with HVUSqPCR parasite detection
RDT, rapid diagnostic test, HVUSqPCR, high volume ultra-sensitive real time polymerase chain reaction; Pf’, Plasmodium falciparum or Plasmodium falciparum mixed 
infection; non-Pf, RDTs distinguish between P. falciparum, and non-P. falciparum, and uninfected blood. In this study only P. vivax was identified by molecular methods 
so non-P. falciparum in an RDT equates with P. vivax; P. spp., Plasmodium species not identified by HVUSqPCR compared against any Plasmodium infection detected by 























 All sites 96 120 4462 55 4733 44 % (38–51 %) 99 % (98–99 %) 64 % (55–71 %) 97 % (97–98 %)
 Cam 1 35 1411 0 1447 3 % (0–15 %) 100 % (99–100 %) 100 % (3–100 %) 98 % (97–98 %)
 TMBA 71 34 1241 37 1383 68 % (58–76 %) 97 % (96–98 %) 66 % (56–75 %) 97 % (96–98 %)
 Viet 24 51 1810 18 1903 32 % (22–44 %) 99 % (98–100 %) 57 % (41–72 %) 97 % (96–98 %)
Non Pf
 All sites 54 332 4332 15 4733 14 % (11–18 %) 100 % (99–100 %) 78 % (67–87 %) 93 % (92–94 %)
 Cam 0 52 1395 0 1447 0 % (0–1 %) 100 % (93–100 %) NA 96 % (95–97 %)
 TMBA 47 180 1153 3 1383 21 % (16–27 %) 100 % (99–100 %) 94 % (84–99 %) 87 % (85–88 %)
 Viet 7 100 1784 12 1903 7 % (3–13 %) 100 % (99–100 %) 37 % (16–62 %) 95 % (94–96 %)
P. spp.
 All sites 20 379 3740 46 4185 5 % (3–8 %) 99 % (98–99 %) 30 % (20–43 %) 91 % (90–92 %)
 Cam 0 145 1218 0 1363 0 % (0–0.3 %) 100 % (97–100 %) NA 89 % (88–91 %)
 TMBA 16 158 873 24 1071 9 % (5–15 %) 97 % (96–98 %) 40 % (25–57 %) 85 % (82–87 %)
 Viet 4 76 1649 22 1751 5 % (1–12 %) 99 % (98–99 %) 15 % (4–35 %) 96 % (95–97 %)
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participants without anaemia (n  =  819) had a geomet-
ric mean (95 % CI) parasite density of 1159 (912–1474) 
parasites/mL, compared to 608 (295–1253) parasites/
ml in those with mild anaemia (n  =  137), and 1787 
(115–27,757) parasites/ml with moderate anaemia. Para-
sitaemic participants who were febrile on the day of the 
survey were more likely to have mild anaemia (11/45; 
24 %) or moderate anaemia (4/45; 9 %) compared to afe-
brile participants (117/841; 14  %; p =  0.05 and 11/841; 
1 %; p = 0.005, respectively).
A multivariate logistic regression model was con-
structed to identify risk factors for parasite carriage (as 
detected by HVUSqPCR), which included anaemia, fever 
at the time of the survey, a history of fever, sex, occupa-
tion, and age group. Of these, only a history of fever, male 
sex, and age equal or older 15 years were independently 
and significantly associated with parasitaemia (Table  6). 
Country specific models identified in addition an inde-
pendent association with a past history of malaria in 
Cambodia and Vietnam (Additional file  7). The models 
did not suggest different risk factors for a low versus a 
high density parasitaemia.
Discussion
This study demonstrates that in areas of the Greater 
Mekong Subregion (GMS) classified as hypoendemic, 
a considerable proportion of asymptomatic individu-
als carry Plasmodium parasites. In the GMS and in 
epidemiologically similar areas in South-East Asia 
and perhaps beyond the prevalence of malaria infec-
tions  seems to have been substantially underestimated. 
The HVUSqPCR  Plasmodium  prevalence estimates in 
Table 4 Species specific sensitivity, specificity, positive predictive value and  negative predictive value of  microscopy 
compared with HVUSqPCR parasite detection
HVUSqPCR, high volume ultra-sensitive real time polymerase chain reaction; Pf, Plasmodium falciparum or Plasmodium falciparum mixed infection; Pv, Plasmodium 
vivax; P. spp., Plasmodium species not identified by HVUSqPCR compared against any Plasmodium infection detected by RDT; Cam, Cambodia; TMBA, Thailand–





















 All sites 62 144 4616 5 4827 30 % (24–37 %) 100 % (99–100 %) 93 % (83–98 %) 97 % (96–97 %)
 Cam 0 36 1410 1 1447 0 % (0–10 %) 100 % (99–100 %) 0 % (0–10 %) 98 % (97–98 %)
 TMBA 37 61 1418 1 1517 38 % (28–48 %) 100 % (99–100 %) 98 % (86–100 %) 96 % (95–97 %)
 Viet 25 47 1788 3 1863 35 % (24–47 %) 100 % (99–100 %) 89 % (72–98 %) 97 % (97–98 %)
Pv
 All sites 141 262 4411 13 4827 35 % (30–40 %) 100 % (99–100 %) 92 % (86–95 %) 94 % (94–95 %)
 Cam 7 45 1395 0 1447 14 % (6–26 %) 100 % (99–100 %) 100 % (59–100 %) 97 % (96–98 %)
 TMBA 99 149 1264 5 1517 40 % (34–46 %) 100 % (99–100 %) 95 % (89–98 % 89 % (89–91 %)
 Viet 35 68 1752 8 1863 34 % (25–44 %) 100 % (99–100 %) 81 % (67–92 %) 96 % (95–97 %)
P. spp
 All sites 13 391 3864 1 4269 3 % (2–5 %) 100 % (99–100 %) 93 % (66–100 %) 91 % (90–92 %)
 Cam 0 145 1218 0 1363 0 % (0–0.3 %) 100 % (97–100 %) NA 89 % (88–91 %)
 TMBA 6 175 1009 0 1190 3 % (1–7 %) 100 % (99–100 %) 100 % (54–100 %) 85 % (83–87 %)
 Viet 7 71 1637 1 1716 9 % (4–18 %) 100 % (99–100 %) 88 % (47–100 %) 96 % (95–97 %)
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11 villages in the GMS were approximately four times 
higher than estimates based on microscopy or RDT. The 
majority of asymptomatic carriers had Plasmodium den-
sities below the lower limits of detection for microscopy, 
as well as for conventional low volume PCR methods 
(around 1000–5000 parasites/mL, compared to 22 para-
sites/mL with HVUSqPCR). Parasite DNA detected by 
HVUSqPCR is likely to represent living parasites, since 
mRNA coding for Plasmodium species is also detectable 
in the same patient samples (Dr. Z. Bozdech, personal 
communication). The findings suggest that the submi-
croscopic parasite reservoir could be important for trans-
mission between seasons. It will be important to study 
the longevity and transmissibility of these infections 
within the human host.
In this study, molecular methods were not used to 
assess gametocytaemia which would require RNA meas-
urement. This represents a limitation of the study since 
light microscopy which was used has a much more lim-
ited sensitivity and did not detect gametocytaemia [25]. 
Submicroscopic levels of gametocytaemia, although less 
efficient, can still transmit malaria [26]. Single point 
prevalence assessments using a much more sensitive 
mRNA method may still only have a limited predictive 
value, since parasitaemia (and presumably gametocytae-
mia) fluctuates over time and gametocytes may accumu-
late in the dermis. Longitudinal studies to assess asexual 
and sexual stage carriage over time using molecular tech-
niques are underway.
There was substantial heterogeneity between villages 
in the ratios between RDT, microscopy and HVUSqPCR 
malaria prevalence rates, which suggests that extrapo-
lation of prevalence from detection rates based on 
the conventional techniques will be imprecise. The 
HVUSqPCR technique used in this study has a lower 
limit of detection of around 100,000 parasites in the 
entire blood volume of an adult and so will still be una-
ble to detect lower circulating parasitaemias or seques-
tered non-circulating parasites [27]. Very low level 
parasitaemias can reflect chronic infections in persons 
with partial immunity or inadequately treated primary 
infections [28–31].
Parasite densities were lower in the selected villages 
in Vietnam and Cambodia compared to the Thailand–
Myanmar border areas. In the Cambodian study villages 
all detected parasitaemias were on or below the threshold 
of parasite densities detectable by microscopy. In assess-
ing these very low parasite densities, false positive PCR 
results are a concern. A rigorous quality control system 
was in place throughout the study, and the consistent 
HVUSqPCR negativity of control samples provide reas-
surance that the prevalence estimates are not inflated.
Fig. 4 The detection rate of microscopy and RDT in relation to 
parasite density
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In 38 specimens, RDTs detected P. falciparum and in 
eight specimens P. vivax parasites while the HVUSqPCR 
was negative. In the PfHRP2-based RDTs for P. falciparum 
this could be due to persistent antigen after the infection 
has been eliminated. PfHRP2 is eliminated slowly and thus 
could accumulate in chronic infections. Alternatively this 
finding could reflect true false positive RDTs. In 411/988 
(42  %) of infections detected by HVUSqPCR, it was not 
possible to determine the Plasmodium species as there 
was insufficient Plasmodium DNA to perform the species 
identifying nested PCRs. Even more sensitive techniques 
will be needed to determine whether the species composi-
tion of these “undetermined infections” is similar to the 
composition of the identified species.
Fig. 5 Prevalence summary by detection method for each study village (sorted by high volume ultra‑sensitive real time polymerase chain reaction; 
HVUSqPCR)
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Fig. 6 Fever in relation to P. falciparum and P. vivax densities
Table 5 Mild and moderate anaemia in relation to P. falciparum and P. vivax infections
HVUSqPCR, high volume ultra-sensitive real time polymerase chain reaction; Hb, haemoglobin; g/dL, grams per decilitre; Pf, P. falciparum, mixed more than one 
Plasmodium species identified; Plasmodium spp., Plasmodium species was not identified; Pv, P. vivax
a Negative = participants without evidence of parasitaemia by HVUSqPCR
b HVUSqPCR assay could not be performed because sample size was not sufficient or other technical reasons
HVUSqPCR results No anaemia; Hb ≥11 g/dL Mild Hb 8–<11 g/dL Moderate Hb <8 g/dL Total
Negativea 3174 82 % 619 16 % 96 2 % 3889
Pf 126 77 % 30 18 % 7 4 % 163
Mixed 45 85 % 7 13 % 1 2 % 53
Plasmodium spp.b 338 84 % 61 15 % 4 1 % 403
Pv 310 88 % 39 11 % 5 1 % 354
Not done 104 60 % 59 34 % 11 6 % 174
Total 4097 81 % 815 16 % 124 2 % 5036
Table 6 Adjusted odds ratios for being HVUSqPCR positive (n = 967), stratified by site, using random effects modelling 
(n total = 4807)
Initial model included anaemia (mild, moderate, none), fever at the time of the surveya  (0/1), history of fever (0/1), sex, occupation (0/1), family member (0/1) and age 
group (<6-month-old, 6-year-old–<15-year-old, and ≥15-year-old)
a Temperature >37.5 °C
b Compared against age <6-year-old [113/616 (18 %)]; age 6-year-old–<15-year-old not significant [203/1126 (18 %), p = 0.11]
Factor No. HVUSqPCR positive with factor (%) No. HVUSqPCR positive without factor (%) Adj. odds ratio 95 % CI
History of fever 105/356 (30 %) 862/4451 (19 %) 1.98 1.54, 2.56
Male 577/2373 (24 %) 390/2434 (16 %) 1.71 1.47, 1.98
Age ≥15b 651/3065 (21 %) Comparatorb 1.69 1.34, 2.13
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Conclusions
The findings of this study have implications for control, 
elimination, and eradication of malaria, and in particular 
for the urgent need to contain and eliminate artemisinin 
resistant falciparum malaria in South-East Asia. Screen-
ing and treatment activities will only identify a minority 
of parasitaemic individuals, and will not eliminate malaria 
rapidly enough to stop the spread of artemisinin and mul-
tidrug resistant malaria [32]. The only way to eliminate 
malaria rapidly in populations with significant subpatent 
malaria prevalence is to treat the entire population with 
effective anti-malarial drugs. How, when and how often 
this should be done needs urgent further exploration.
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